Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC ... positive epatitis-B-surface-antigen (HBV), alpha-fetoprotein increase, and echo features including septa, calcification ...

RT-PCR test quantifying CP mRNA in blood can detect hepatocellular carcinoma early—especially in AFP-negative cases—offering ...

In early-stage HCC patients (BCLC 0 and A), CP mRNA was elevated in 67.9% of cases, outperforming AFP, which detected only 46 ...

EvoLiver, a blood test that detects early-stage liver cancer with high accuracy, has gained breakthrough device designation ...

Liver transplantation is the sole curative option for HCC, but new therapies prompt reconsideration of transplant timing and ...

Hepatocellular carcinoma (HCC ... The use of ultrasound, along with alpha-fetoprotein (AFP) testing, is common for surveillance. However, these methods have limitations in terms of sensitivity ...

Hepatocellular carcinoma (HCC ... narrow resection margins (≤2 cm), high alpha-fetoprotein levels (≥400 ng/mL), and microvascular or macrovascular invasion. Conversely, late-recurrence ...

The AFP test is particularly useful in monitoring patients with liver cirrhosis, as they are at increased risk for developing hepatocellular carcinoma. A study published in Hepatology revealed ...

Hepatocellular carcinoma (HCC), the most common form of liver cancer, continues to pose a significant global health challenge ...

Systemic therapy represents the standard of care treatment for patients with advanced hepatocellular carcinoma (HCC). Given the increased risk of death from cirrhosis-related complications in patients ...